ZBTB34 and adrenal cortex carcinoma: Highly expressed ZBTB34 was associated with a poor prognosis of overall survival for adenoid cystic carcinoma (ACC) (P=0.00068), BRAC (P=0.038), COAD (P=0.013), and LIHC (P=0.011), as seen in the survival map of all tumors in Figure 2A.